Can a Relaxometer Improve Cognitive Impairment of Fibromyalgia Patients (Fibrorilax)
Fibromyalgia Syndrome, Fibromyalgia, Pain, Chronic
About this trial
This is an interventional supportive care trial for Fibromyalgia Syndrome focused on measuring Relaxometer, Mini Mental State Examination, Fibromyalgia Impact Questionnaire, Cognitive Impairment, Rehabilitation, Fingers
Eligibility Criteria
Inclusion Criteria:
- Fibromyalgic Syndrome diagnosed according to the criteria of American College of Rheumatology 2016 (ACR 2016)
- moderate-severe cognitive impairment according to the Symptoms Severity Score (SS)
- informed consent gathered
Exclusion Criteria:
- contraindication to passive handling of fingers (severe arthritis, fractures or unconsolidated traumatic outcomes, not healed wounds, finger amputations, contact allergies to substances contained in the relaxometer)
- informed consent not gathered
- drug addiction
- brain stroke
Withdrawal from study
- withdrawal of informed consent
- treatment non completed
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Relaxometer fibromyalgia cases
Relaxometer controls
Repetition 6 minutes pre-set programme with the relaxometer 60 seconds 34 movements/minute 3 seconds 55 movements/minute 60 seconds 34 movements/minute 60 seconds 55 movements/minute 90 seconds 34 movements/minute 5 seconds 55 movements/minute 90 seconds 34 movements/minute
Repetition 6 minutes pre-set programme with the relaxometer 60 seconds 34 movements/minute 3 seconds 55 movements/minute 60 seconds 34 movements/minute 60 seconds 55 movements/minute 90 seconds 34 movements/minute 5 seconds 55 movements/minute 90 seconds 34 movements/minute